Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta‐aggregation-Reference-Cited by-同舟云学术

Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta‐aggregation

Published:2021-02-26 Issue:3 Volume:7 Page:191-202
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Pathol Clin Res

Author:

Lim Shujing Jane¹²^ORCID,Gurusamy Kurinchi²,O'Connor Daniel³,Shaaban Abeer M⁴⁵^ORCID,Brierley Daniel⁶,Lewis Ian⁷,Harrison David⁸^ORCID,Kendall Timothy James⁹^ORCID,Robinson Max¹^ORCID

Affiliation:

1. Department of Cellular Pathology Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle Upon Tyne UK

2. Division of Surgery and Interventional Sciences University College London London UK

3. The Medicines and Healthcare Products Regulatory Agency London UK

4. Department of Histopathology Queen Elizabeth Hospital Birmingham Birmingham UK

5. Institute of Cancer and Genomic Sciences University of Birmingham Birmingham UK

6. Unit of Oral and Maxillofacial Pathology University of Sheffield Sheffield UK

7. National Cancer Research Institute London UK

8. University of St Andrews St Andrews UK

9. University of Edinburgh Centre for Inflammation Research, University of Edinburgh Edinburgh UK

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.199

Reference74 articles.

1. Randomised controlled trials - the gold standard for effectiveness research

2. National Institute for Health Research.Clinical Trials Guide.2019. [Accessed 7 July 2020]. Available from:https://www.nihr.ac.uk/documents/clinical-trials-guide/20595

3. A simplified guide to randomized controlled trials

4. Standard 2: Containing Risk of Bias

5. Completeness of protocols for clinical trials in children submitted to ethics committees

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promoting Best Practice in Cancer Care in Sub Saharan Africa;Frontiers in Medicine;2022-07-06

2. Assessment of clinical trial protocols for pathology content using the SPIRIT‐Path guidelines highlights areas for improvement;The Journal of Pathology: Clinical Research;2022-05-31

3. Digital Pathology Transformation in a Supraregional Germ Cell Tumour Network;Diagnostics;2021-11-25

4. Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension;The Lancet Oncology;2021-10